Regulatory management option analysis
The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.
For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.
Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.
The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.
RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.
Further information
Last updated 23 december 2020. Database contains 260 unique substances/entries.
231-589-4 | 7646-79-9 | ECHA | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 24/10/2018 | Details | |
231-512-4 | 7601-90-3 | Germany | Endocrine disruption | Under development | Under development | No suggestion yet | 13/06/2016 | Details | |
231-158-0 | 7440-48-4 | Netherlands | Carcinogenic Mutagenic Toxic for reproduction | Under development | On hold | No suggestion yet | 09/11/2017 | Details | |
231-150-7 | 7440-41-7 | Germany | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Other | 19/12/2016 | Details | |
231-106-7 | 7439-97-6 | Sweden | Other human toxicity STOT RE Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 23/09/2014 | Details | |
231-106-7 | 7439-97-6 | Denmark | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Other | 15/10/2018 | Details | |
231-100-4 | 7439-92-1 | Sweden | Other environmental toxicity Other human toxicity Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 13/10/2017 | Details | |
230-528-9 | 7173-62-8 | Sweden | STOT RE | Concluded | No need to initiate further regulatory risk management action at this time | None | 26/04/2019 | Details | |
229-176-9 | 6422-86-2 | France | Carcinogenic Endocrine disruption Mutagenic Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 25/01/2019 | Details | |
227-534-9 | 5873-54-1 | Germany | Respiratory sensitiser Skin sensitiser Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 23/09/2014 | Details | |
227-534-9 | 5873-54-1 | Denmark | Respiratory sensitiser Skin sensitiser Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 10/10/2019 | Details | |
226-378-9 | 5384-21-4 | France | Endocrine disruption Persistence Toxic for reproduction Widespread use | Under development | Under development | No suggestion yet | 11/03/2016 | Details | |
225-863-2 | 5124-30-1 | Germany | Respiratory sensitiser Skin sensitiser | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 23/09/2014 | Details | |
225-768-6 | 5064-31-3 | Denmark | Carcinogenic Mutagenic Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 23/09/2014 | Details | |
225-625-8 | 4979-32-2 | Germany | Bioaccumulation Exposure Persistence Widespread use | Under development | Under development | No suggestion yet | 28/02/2019 | Details | |
223-861-6 | 4098-71-9 | Sweden | Exposure Mutagenic Skin sensitiser | Concluded | No need to initiate further regulatory risk management action at this time | None | 09/02/2018 | Details | |
223-861-6 | 4098-71-9 | Germany | Carcinogenic Exposure Mutagenic Other human toxicity | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 10/10/2019 | Details | |
223-445-4 | 3896-11-5 | Germany | Carcinogenic Mutagenic Toxic for reproduction | Under development | Under development | No suggestion yet | 05/12/2014 | Details | |
223-383-8 | 3864-99-1 | Germany | Bioaccumulation Carcinogenic Mutagenic Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 10/07/2015 | Details | |
222-871-8 | 3644-11-9 | Sweden | Carcinogenic Mutagenic | Under development | Under development | No suggestion yet | 08/04/2020 | Details | |
222-583-2 | 3542-36-7 | Netherlands | Carcinogenic Mutagenic Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 10/10/2019 | Details | |
221-967-7 | 3296-90-0 | Norway | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 07/01/2020 | Details | |
221-641-4 | 3173-72-6 | Germany | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 10/10/2019 | Details | |
221-573-5 | 3147-75-9 | Germany | Bioaccumulation Other environmental toxicity Persistence | Under development | Under development | No suggestion yet | 05/12/2014 | Details | |
220-474-4 | 2778-42-9 | Germany | Respiratory sensitiser Skin sensitiser | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 23/09/2014 | Details | |
220-239-6 | 2682-20-4 | Denmark | Skin sensitiser | Concluded | Appropriate to initiate regulatory risk management action | Other legislation | 04/05/2015 | Details | |
219-799-4 | 2536-05-2 | Germany | Respiratory sensitiser Skin sensitiser | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 23/09/2014 | Details | |
219-799-4 | 2536-05-2 | Denmark | Carcinogenic Mutagenic Respiratory sensitiser Skin sensitiser Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 10/10/2019 | Details | |
219-470-5 | 2440-22-4 | Germany | Other human toxicity Persistence Toxic for reproduction | Under development | Under development | No suggestion yet | 05/12/2014 | Details | |
219-154-7 | 2374-14-3 | Netherlands | Bioaccumulation Other human toxicity Persistence | Concluded | Appropriate to initiate regulatory risk management action | CLH | 10/07/2015 | Details | |
218-165-4 | 2058-94-8 | Germany | Bioaccumulation Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 07/03/2017 | Details | |
217-533-1 | 1879-09-0 | France | Carcinogenic Mutagenic Skin sensitiser Toxic for reproduction | Under development | Under development | No suggestion yet | 07/03/2017 | Details | |
217-442-7 | 1852-16-0 | Sweden | Carcinogenic Mutagenic | Under development | Under development | No suggestion yet | 08/04/2020 | Details | |
216-036-7 | 1478-61-1 | Sweden | Endocrine disruption | Concluded | Appropriate to initiate regulatory risk management action | CLH | 20/12/2018 | Details | |
215-607-8 | 1333-82-0 | Netherlands | Carcinogenic Mutagenic Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 23/03/2020 | Details | |
215-535-7 | 1330-20-7 | Germany | Carcinogenic Mutagenic Respiratory sensitiser STOT RE Toxic for reproduction | Under development | Under development | No suggestion yet | 24/06/2020 | Details | |
215-271-2 | 1317-40-4 | ECHA | Carcinogenic Mutagenic Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 08/10/2015 | Details | |
215-204-7 | 1313-27-5 | Denmark | Carcinogenic Mutagenic Persistence Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 08/12/2020 | Details | |
215-185-5 | 1310-73-2 | Sweden | Other human toxicity | Concluded | No need to initiate further regulatory risk management action at this time | Other | 08/04/2015 | Details | |
215-181-3 | 1310-58-3 | Sweden | Other human toxicity | Concluded | No need to initiate further regulatory risk management action at this time | Other | 08/04/2015 | Details | |
215-157-2 | 1308-06-1 | Netherlands | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 09/06/2017 | Details | |
215-133-1 | 1304-56-9 | Netherlands | Carcinogenic | Under development | Under development | No suggestion yet | 09/11/2017 | Details | |
214-946-9 | 1222-05-5 | France | Endocrine disruption | Concluded | Appropriate to initiate regulatory risk management action | Other | 28/01/2020 | Details | |
214-317-9 | 1120-71-4 | ECHA | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 06/02/2015 | Details | |
214-012-0 | 1072-63-5 | Sweden | Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 07/01/2020 | Details | |
213-934-0 | 1067-53-4 | ECHA | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | CLH | 13/06/2016 | Details | |
213-103-2 | 924-42-5 | Sweden | Carcinogenic Mutagenic | Under development | Under development | No suggestion yet | 01/09/2020 | Details | |
212-828-1 | 872-50-4 | Commission | Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 25/10/2018 | Details | |
212-485-8 | 822-06-0 | Germany | Endocrine disruption Skin sensitiser | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 23/09/2014 | Details | |
212-039-2 | 753-73-1 | Netherlands | Other human toxicity | Concluded | Appropriate to initiate regulatory risk management action | Other legislation | 10/07/2015 | Details | |
Route: .live2